NEXIEN BIOPHARMA (NXEN) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 10 30 sessions, July 24, 2025 to August 6, 2026
- Largest daily move
- +821.4% close of August 28, 2025
- 1-year change
- -98.2% closing prices, July 24, 2025 to August 6, 2026
- 5-year change
- -99.9% closing prices, August 6, 2021 to August 6, 2026
Company Description
NEXIEN BIOPHARMA (OTC: NXEN) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $7.1K.
NXEN has declined 98.2% over the past year. The last closing price was $0.0001.
For FY2024, NEXIEN BIOPHARMA and diluted earnings per share of $0.00.
This page collects what Stock Titan holds for NXEN, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
NEXIEN BIOPHARMA (NXEN) closed at $0.0001 on August 6, 2026. Over the past 12 months, the price has lost 98.2%.
NXEN Metrics & Rankings
Price returns through August 6, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
NEXIEN BIOPHARMA has 1 recent news article. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. View all NXEN news →
SEC Filings
NEXIEN BIOPHARMA has filed 1 recent SEC filing, including 1 Form 15-12G. The most recent filing was submitted on September 19, 2025. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all NXEN SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
NXEN Company Profile & Sector Positioning
NEXIEN BIOPHARMA (NXEN) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing NXEN often look at related companies in the same sector, including ADASTRA HOLDINGS LTD (XTXXF), RIMROCK GOLD CORP (RMRK), KAYA HOLDINGS INC (KAYS), PHARMADRUG INC (LMLLF), and CANN AMERICAN CORP (CNNA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate NXEN's relative position within its industry.